Core Viewpoint - The article discusses the ongoing legal actions regarding investor claims against Yitong Century (宜通世纪), highlighting the company's financial misconduct and the potential for investors to seek compensation through legal channels [1][2][3]. Group 1: Legal Proceedings - On January 13, 2026, the Shanghai Jiucheng Law Firm, represented by lawyer Xu Feng, submitted another case for investor claims against Yitong Century to the Guangzhou Intermediate People's Court [1]. - Some previous investor claims handled by Xu Feng have already reached settlements, and the firm continues to accept new claims from other investors [1][3]. Group 2: Financial Misconduct - On June 21, 2023, Yitong Century received an administrative penalty decision from the China Securities Regulatory Commission (CSRC) due to significant financial misconduct [2][3]. - Between May 1 and December 31, 2017, Yitong Century's subsidiary, Beitai Health, engaged in financial fraud, inflating revenue by 97.34 million yuan, costs by 52.61 million yuan, and total profits by 40.84 million yuan, which represented 3.7%, 9.75%, and 15.67% of the company's reported figures, respectively [2][4]. Group 3: Investor Compensation Eligibility - Investors who purchased Yitong Century shares between April 3, 2018, and November 4, 2022, and sold or continued to hold their shares after November 4, 2022, are eligible to file for compensation based on previous favorable judgments [5].
宜通世纪(300310)索赔案再向法院提交立案,此前已有投资者胜诉及获赔